8月9日，光明区举办健康大讲堂第90期活动，由中山大学肿瘤防治中心、广州医科大学附属第一医院、深圳市人民医院、中国医学科学院肿瘤医院深圳医院、中山大学孙逸仙纪念医院等5家医疗机构的12位专家为近500名居民科普鼻咽癌防治知识[1]。活动针对这一被称为"广东癌"的疾病进行了系统介绍，重点涵盖早期症状识别、筛查诊断、治疗方式及放疗后康复管理等内容[1]。
根据专家介绍，2022年全球新发鼻咽癌病例约12万例，其中我国新发病例约占40%[1]。令人遗憾的是，约70%的患者初诊时已属于局部晚期[1]。对此，专家强调早期发现的重要性——早期（Ⅰ/Ⅱ期）患者接受规范治疗后，5年生存率可超过90%[1]。
为帮助居民及时识别病情，专家列举了鼻咽癌的早期症状，包括回吸性鼻涕带血、单侧鼻塞或耳鸣、颈部无痛性肿块和持续性头痛[1]。专家指出，如出现上述症状且持续超过两周，应及时就诊[1]。活动现场还设置了答疑和义诊服务，为居民的健康疑虑提供专业指导[1]。
On August 9, Guangming District hosted the 90th session of its Health Lecture Series, bringing together 12 specialists from five leading medical institutions to educate nearly 500 residents about nasopharyngeal cancer prevention and control [1]. The participating hospitals included Sun Yat-sen University Cancer Prevention and Treatment Center, the First Affiliated Hospital of Guangzhou Medical University, Shenzhen People's Hospital, Cancer Hospital of the Chinese Academy of Medical Sciences Shenzhen Hospital, and Sun Yat-sen Memorial Hospital [1].
The experts focused on early symptom recognition, screening and diagnostic methods, treatment approaches, and post-radiotherapy rehabilitation management for nasopharyngeal cancer [1]. They emphasized that patients diagnosed at early stages (Stage I/II) who receive standard treatment can achieve a five-year survival rate exceeding 90% [1]. However, approximately 70% of patients are already at locally advanced stages upon initial diagnosis [1]. Residents were advised to seek immediate medical attention if they experience warning signs lasting more than two weeks, including bloody nasal discharge upon nasal suctioning, unilateral nasal obstruction or tinnitus, painless neck masses, or continuous headaches [1].
Globally, approximately 120,000 new cases of nasopharyngeal cancer were reported in 2022, with China accounting for roughly 40% of these cases [1]. The event included on-site question-and-answer sessions and free clinical consultations to help residents better understand the disease and recognize its early manifestations [1].
